Updated:
TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a publicly traded women's health pharmaceutical company founded by Robert G.
TherapeuticsMD, Inc.
TherapeuticsMD was founded in 2000 and is headquartered in Boca Raton, Florida. The company focuses on developing and commercializing women's healthcare products, particularly hormone therapies for menopause and female sexual health (per public filings). The firm's primary product lines include Bijuva (a bio-identical hormone therapy) and Imvexxy (an estrogen vaginal capsule), both approved by the FDA. TherapeuticsMD has historically operated as a commercial-stage company, generating revenue through product sales. Its strategy involves internal R&D, regulatory approvals, and out-licensing or co-marketing arrangements. The company went public in 2002 on the NYSE American. As of 2026, it had not disclosed a formal AUM or assets under management, as it is a pharmaceutical enterprise rather than an investment vehicle. No additional offices or philanthropic arms are publicly recorded. Structurally, TherapeuticsMD is a publicly traded firm, distinct from the family-office or asset-manager profiles typical of Altss coverage. Its governance follows SEC disclosure rules, with board oversight and quarterly financial reporting.
General information
Firm type
Publicly Traded Pharmaceutical Company
Year founded
2000
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boca Raton
Corporate office
Boca Raton, FL, United States
Principals
Robert G. Finizio
CEO
Brian Bernick
Executive Vice President and Chief Commercial Officer
Sector focus
Frequently asked questions
Who manages investment decisions at TherapeuticsMD?
As a publicly traded company, strategic decisions are made by the board of directors and executive management led by CEO Robert G. Finizio. The firm does not operate as an investment office.
What is TherapeuticsMD's core business focus?
The company specializes in women's healthcare, developing and commercializing FDA-approved hormone therapy products for menopause and female sexual health (per public filings).
Does TherapeuticsMD act as a family office or asset manager?
No. TherapeuticsMD is a commercial-stage pharmaceutical company, not an investment vehicle. It is classified under 'other' in Altss coverage due to its business model.
What are TherapeuticsMD's main products?
Key products include Bijuva (estradiol and progesterone) and Imvexxy (estradiol vaginal inserts), both approved by the FDA. The company also developed Annovera, a contraceptive ring.
How is TherapeuticsMD regulated?
As a public company traded on the NYSE American, it is regulated by the SEC. Its products are subject to FDA oversight for safety and efficacy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: